Cargando…
Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
AIMS: Upregulation of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) contributes to the pathogenesis of cardiovascular disease, including hypertension. Transgenic rats expressing the human angiotensinogen gene [TGR (hAGT)L1623] are a new novel humanized model of hypertension that associates...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344767/ https://www.ncbi.nlm.nih.gov/pubmed/37456012 http://dx.doi.org/10.1016/j.heliyon.2023.e17851 |
_version_ | 1785072932497653760 |
---|---|
author | Sun, Xiaoqiang Cao, Jing Chen, Zhe Liu, Yixi VonCannon, Jessica L. Cheng, Heng Jie Ferrario, Carlos M. Cheng, Che Ping |
author_facet | Sun, Xiaoqiang Cao, Jing Chen, Zhe Liu, Yixi VonCannon, Jessica L. Cheng, Heng Jie Ferrario, Carlos M. Cheng, Che Ping |
author_sort | Sun, Xiaoqiang |
collection | PubMed |
description | AIMS: Upregulation of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) contributes to the pathogenesis of cardiovascular disease, including hypertension. Transgenic rats expressing the human angiotensinogen gene [TGR (hAGT)L1623] are a new novel humanized model of hypertension that associates with declines in cardiac contractile function and β-adrenergic receptor (AR) reserve. The molecular mechanisms are unclear. We tested the hypothesis that in TGR (hAGT)L1623 rats, left ventricular (LV) myocyte CaMKIIδ and β(3)-AR are upregulated, but β(1)-AR is down-regulated, which are important causes of cardiac dysfunction and β-AR desensitization. MAIN METHODS: We compared LV myocyte CaMKIIδ, CaMKIIδ phosphorylation (at Thr287) (pCaMKIIδ), and β(1)-and β(3)-AR expressions and determined myocyte functional and [Ca(2+)](I) transient ([Ca(2+)](iT)) responses to β-AR stimulation with and without pretreatment of myocytes using an inhibitor of CaMKII, KN-93 (10(−6) M, 30 min) in male Sprague Dawley (SD; N = 10) control and TGR (hAGT)L1623 (N = 10) adult rats. KEY FINDINGS: Hypertension in TGR (hAGT)L1623 rats was accompanied by significantly increased LV myocyte β(3)-AR protein levels and reduced β(1)-AR protein levels. CaMKIIδ phosphorylation (at Thr287), pCaMKIIδ was significantly increased by 35%. These changes were followed by significantly reduced basal cell contraction (dL/dt(max)), relaxation (dR/dt(max)), and [Ca(2+)](iT). Isoproterenol (10(−8) M) produced significantly smaller increases in dL/dt(max), dR/dt(max), and [Ca(2+)](iT). Moreover, only in TGR (hAGT)L1623 rats, pretreatment of LV myocytes with KN-93 (10(−6) M, 30 min) fully restored normal basal and isoproterenol-stimulated myocyte contraction, relaxation, and [Ca(2+)](iT). SIGNIFICANCE: LV myocyte CaMKIIδ overactivation with associated contrast changes in β(3)-AR and β(1)-AR may be the key molecular mechanism for the abnormal contractile phenotype and β-AR desensitization in this humanized model of hypertension. |
format | Online Article Text |
id | pubmed-10344767 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-103447672023-07-15 Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension Sun, Xiaoqiang Cao, Jing Chen, Zhe Liu, Yixi VonCannon, Jessica L. Cheng, Heng Jie Ferrario, Carlos M. Cheng, Che Ping Heliyon Research Article AIMS: Upregulation of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) contributes to the pathogenesis of cardiovascular disease, including hypertension. Transgenic rats expressing the human angiotensinogen gene [TGR (hAGT)L1623] are a new novel humanized model of hypertension that associates with declines in cardiac contractile function and β-adrenergic receptor (AR) reserve. The molecular mechanisms are unclear. We tested the hypothesis that in TGR (hAGT)L1623 rats, left ventricular (LV) myocyte CaMKIIδ and β(3)-AR are upregulated, but β(1)-AR is down-regulated, which are important causes of cardiac dysfunction and β-AR desensitization. MAIN METHODS: We compared LV myocyte CaMKIIδ, CaMKIIδ phosphorylation (at Thr287) (pCaMKIIδ), and β(1)-and β(3)-AR expressions and determined myocyte functional and [Ca(2+)](I) transient ([Ca(2+)](iT)) responses to β-AR stimulation with and without pretreatment of myocytes using an inhibitor of CaMKII, KN-93 (10(−6) M, 30 min) in male Sprague Dawley (SD; N = 10) control and TGR (hAGT)L1623 (N = 10) adult rats. KEY FINDINGS: Hypertension in TGR (hAGT)L1623 rats was accompanied by significantly increased LV myocyte β(3)-AR protein levels and reduced β(1)-AR protein levels. CaMKIIδ phosphorylation (at Thr287), pCaMKIIδ was significantly increased by 35%. These changes were followed by significantly reduced basal cell contraction (dL/dt(max)), relaxation (dR/dt(max)), and [Ca(2+)](iT). Isoproterenol (10(−8) M) produced significantly smaller increases in dL/dt(max), dR/dt(max), and [Ca(2+)](iT). Moreover, only in TGR (hAGT)L1623 rats, pretreatment of LV myocytes with KN-93 (10(−6) M, 30 min) fully restored normal basal and isoproterenol-stimulated myocyte contraction, relaxation, and [Ca(2+)](iT). SIGNIFICANCE: LV myocyte CaMKIIδ overactivation with associated contrast changes in β(3)-AR and β(1)-AR may be the key molecular mechanism for the abnormal contractile phenotype and β-AR desensitization in this humanized model of hypertension. Elsevier 2023-06-30 /pmc/articles/PMC10344767/ /pubmed/37456012 http://dx.doi.org/10.1016/j.heliyon.2023.e17851 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Sun, Xiaoqiang Cao, Jing Chen, Zhe Liu, Yixi VonCannon, Jessica L. Cheng, Heng Jie Ferrario, Carlos M. Cheng, Che Ping Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension |
title | Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension |
title_full | Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension |
title_fullStr | Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension |
title_full_unstemmed | Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension |
title_short | Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension |
title_sort | increased camkii activation and contrast changes of cardiac β1-and β3-adrenergic signaling pathways in a humanized angiotensinogen model of hypertension |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344767/ https://www.ncbi.nlm.nih.gov/pubmed/37456012 http://dx.doi.org/10.1016/j.heliyon.2023.e17851 |
work_keys_str_mv | AT sunxiaoqiang increasedcamkiiactivationandcontrastchangesofcardiacb1andb3adrenergicsignalingpathwaysinahumanizedangiotensinogenmodelofhypertension AT caojing increasedcamkiiactivationandcontrastchangesofcardiacb1andb3adrenergicsignalingpathwaysinahumanizedangiotensinogenmodelofhypertension AT chenzhe increasedcamkiiactivationandcontrastchangesofcardiacb1andb3adrenergicsignalingpathwaysinahumanizedangiotensinogenmodelofhypertension AT liuyixi increasedcamkiiactivationandcontrastchangesofcardiacb1andb3adrenergicsignalingpathwaysinahumanizedangiotensinogenmodelofhypertension AT voncannonjessical increasedcamkiiactivationandcontrastchangesofcardiacb1andb3adrenergicsignalingpathwaysinahumanizedangiotensinogenmodelofhypertension AT chenghengjie increasedcamkiiactivationandcontrastchangesofcardiacb1andb3adrenergicsignalingpathwaysinahumanizedangiotensinogenmodelofhypertension AT ferrariocarlosm increasedcamkiiactivationandcontrastchangesofcardiacb1andb3adrenergicsignalingpathwaysinahumanizedangiotensinogenmodelofhypertension AT chengcheping increasedcamkiiactivationandcontrastchangesofcardiacb1andb3adrenergicsignalingpathwaysinahumanizedangiotensinogenmodelofhypertension |